Cypress Bioscience Inc. reported a larger fiscal third-quarter loss Tuesday after it licensed a series of new drug candidates as part of its plan to focus on treatments for central nervous system disorders.
Health officials say ADHD is becoming more common in the U.S. The latest study says nearly 1 in 10 children ages 4 through 17 has been diagnosed with it.
Federal prosecutors said Tuesday they have charged a former GlaxoSmithKline executive with obstructing justice and making false statements in an effort to conceal illegal promotion of a company drug.
For the second time this year, federal inspectors have dismissed allegations by Food and Drug Administration scientists who say they were pressured into approving medical devices.
Researchers from University of North Carolina Lineberger Comprehensive Cancer Center identified a protein called RGL2 as an attractive target making a KRAS-blocking drug.
By tracking the flow of information in a cell preparing to split, Johns Hopkins scientists have identified a protein mechanism that coordinates and regulates the dynamics of shape change necessary for division of a single cell into two daughter cells.
XOMA Ltd. announced that the U.S. Patent and Trademark Office today issued two new patents to XOMA as part of the company's expanding intellectual property portfolio around its XOMA 052 antibody to interleukin-1 beta (IL-1 beta).
Omthera Pharmaceuticals, Inc. announced the initiation of a randomized, open-label, four-way cross-over pharmacokinetics study to evaluate the bioavailability of Epanova, Omthera’s lead compound for the treatment of very high triglycerides.
QIAGEN has launched several new products that assist in the molecular analysis of formalin-fixed, paraffin-embedded (FFPE) tissue samples.
NanoString Technologies, Inc. launched a novel solution for detecting genetic copy number variations (CNVs) associated with disease susceptibility, drug response, and cancer progression.
GE Healthcare announced that Dr. Michael Freeley from the Institute of Molecular Medicine, Trinity College Dublin is winner of the first GE Healthcare HCA Award.
ISPE announced that Genentech’s ECP-1 Bacterial Manufacturing Facility is the overall winner of the 2010 Facility of the Year Awards (FOYA) program.
Abbott and the Clinton Health Access Initiative (CHAI) have joined forces to provide HIV testing to infants in all countries working in partnership with the CHAI.
The Global Alliance for TB Drug Development (TB Alliance) announced the launch of the first clinical trial to test a novel tuberculosis regimen in a new development paradigm designed to speed new treatments to patients.
According to a new report released today by Citeline Drug Intelligence, the 240th meeting of the American Chemical Society disappointed expectations with a lack of new drug targets being announced at the event.